Le Lézard
Classified in: Science and technology
Subjects: Product/Service, Survey

Incisiv and MarketDial Unveil New Research on Improving Success Rates and ROI of Strategic Store Initiatives


Incisiv, a leading consumer industries insights firm, and MarketDial, a software company that helps retailers optimize their in-store testing and experimentation, today released key findings from a new study focused on improving success rates and ROI of retailers' strategic brick and mortar initiatives. The research highlights that retailers must adopt a structured and data-driven approach to in-store testing to improve the success rates and ROI of their strategic store initiatives.

The study is based on a survey of 200 retail executives in the United States. The study was conducted from Feb 9, 2023 - Mar 3, 2023. Key findings from the research include:

"At MarketDial, we firmly believe that scientific in-store testing is a necessary muscle that retailers need to build and maintain success and profitability," said Morgan Davis, CEO and Co-Founder of MarketDial. "Incisiv's research shows that adopting advanced in-store testing tools and technology can drive data-driven decisions for retailers and help them identify and optimize high-impact initiatives before scaling, ensuring maximum impact."

"Retailers invest millions of dollars into strategic store initiatives, ranging from high value ones such as store remodels to high velocity ones such as making price changes across key categories. Yet, the rate of failed initiatives remains high, resulting in significant losses and missed opportunities," said Giri Agarwal, Chief Strategy Officer, Incisiv. "Our research shows that improving the maturity of in-store testing processes and systems is critical to drive greater success and ROI from these investments."

The full report, "Boosting Success Rates and ROI of Strategic Store Initiatives," is available here.

About Incisiv

Incisiv is a peer-to-peer executive network and industry insights firm for consumer industry executives navigating digital disruption. Incisiv offers curated executive learning, digital maturity benchmarks, and prescriptive transformation insights to clients across the consumer and technology industry spectrum. Visit incisiv.com for more information.

About MarketDial

MarketDial provides retailers with the tools they need to validate initiatives quickly and confidently. Our mission is to maximize our clients' potential by offering accurate testing solutions and actionable insights. With our automated analytics and in-store testing tools, businesses can trust they are making data-driven decisions that drive success. Visit Marketdial.com for more information.


These press releases may also interest you

at 00:00
XSOOH has always been at the forefront of hair care innovation, striving to deliver cutting-edge  products  that enhance the way customers achieve their desired looks. In a world where time is precious, XSOOH  proudly announces the launch of the...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...

3 jui 2024
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

3 jui 2024
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

3 jui 2024
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

3 jui 2024
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...



News published on and distributed by: